nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A5—Ifosfamide—germ cell cancer	0.201	0.25	CbGbCtD
Halofantrine—CYP2C8—Ifosfamide—germ cell cancer	0.193	0.24	CbGbCtD
Halofantrine—CYP3A5—Etoposide—germ cell cancer	0.096	0.119	CbGbCtD
Halofantrine—CYP2C8—Etoposide—germ cell cancer	0.0923	0.115	CbGbCtD
Halofantrine—CYP3A4—Ifosfamide—germ cell cancer	0.0783	0.0973	CbGbCtD
Halofantrine—CYP2D6—Vinblastine—germ cell cancer	0.0654	0.0812	CbGbCtD
Halofantrine—CYP3A4—Vinblastine—germ cell cancer	0.0416	0.0516	CbGbCtD
Halofantrine—CYP3A4—Etoposide—germ cell cancer	0.0374	0.0465	CbGbCtD
Halofantrine—Haemolysis—Cisplatin—germ cell cancer	0.00769	0.0394	CcSEcCtD
Halofantrine—Tetany—Cisplatin—germ cell cancer	0.0075	0.0385	CcSEcCtD
Halofantrine—Haematocrit decreased—Methotrexate—germ cell cancer	0.0036	0.0185	CcSEcCtD
Halofantrine—Cerebrovascular accident—Vinblastine—germ cell cancer	0.00291	0.0149	CcSEcCtD
Halofantrine—Rigors—Etoposide—germ cell cancer	0.00274	0.0141	CcSEcCtD
Halofantrine—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.00274	0.014	CcSEcCtD
Halofantrine—Pulmonary oedema—Ifosfamide—germ cell cancer	0.00252	0.0129	CcSEcCtD
Halofantrine—Cerebrovascular accident—Bleomycin—germ cell cancer	0.00246	0.0126	CcSEcCtD
Halofantrine—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00228	0.0117	CcSEcCtD
Halofantrine—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00197	0.0101	CcSEcCtD
Halofantrine—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00181	0.00929	CcSEcCtD
Halofantrine—Stomatitis—Bleomycin—germ cell cancer	0.00181	0.00928	CcSEcCtD
Halofantrine—Face oedema—Cisplatin—germ cell cancer	0.00171	0.00879	CcSEcCtD
Halofantrine—Stomatitis—Dactinomycin—germ cell cancer	0.00169	0.00865	CcSEcCtD
Halofantrine—Pollakiuria—Ifosfamide—germ cell cancer	0.00164	0.00843	CcSEcCtD
Halofantrine—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00162	0.00831	CcSEcCtD
Halofantrine—Ill-defined disorder—Vinblastine—germ cell cancer	0.00159	0.00817	CcSEcCtD
Halofantrine—Malaise—Vinblastine—germ cell cancer	0.00155	0.00794	CcSEcCtD
Halofantrine—Stomatitis—Ifosfamide—germ cell cancer	0.00155	0.00793	CcSEcCtD
Halofantrine—Chills—Bleomycin—germ cell cancer	0.0015	0.00767	CcSEcCtD
Halofantrine—Convulsion—Vinblastine—germ cell cancer	0.00149	0.00763	CcSEcCtD
Halofantrine—Discomfort—Vinblastine—germ cell cancer	0.00144	0.00741	CcSEcCtD
Halofantrine—Chills—Dactinomycin—germ cell cancer	0.00139	0.00715	CcSEcCtD
Halofantrine—Visual impairment—Ifosfamide—germ cell cancer	0.00137	0.00704	CcSEcCtD
Halofantrine—Ill-defined disorder—Bleomycin—germ cell cancer	0.00135	0.0069	CcSEcCtD
Halofantrine—Anorexia—Vinblastine—germ cell cancer	0.00134	0.00685	CcSEcCtD
Halofantrine—Stomatitis—Cisplatin—germ cell cancer	0.00133	0.00684	CcSEcCtD
Halofantrine—Tinnitus—Ifosfamide—germ cell cancer	0.00133	0.00681	CcSEcCtD
Halofantrine—Malaise—Bleomycin—germ cell cancer	0.00131	0.00671	CcSEcCtD
Halofantrine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.0013	0.00664	CcSEcCtD
Halofantrine—Chills—Ifosfamide—germ cell cancer	0.00128	0.00655	CcSEcCtD
Halofantrine—Arrhythmia—Ifosfamide—germ cell cancer	0.00127	0.00652	CcSEcCtD
Halofantrine—Cough—Bleomycin—germ cell cancer	0.00127	0.00649	CcSEcCtD
Halofantrine—Paraesthesia—Vinblastine—germ cell cancer	0.00126	0.00645	CcSEcCtD
Halofantrine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00126	0.00644	CcSEcCtD
Halofantrine—Chest pain—Bleomycin—germ cell cancer	0.00123	0.00633	CcSEcCtD
Halofantrine—Myalgia—Bleomycin—germ cell cancer	0.00123	0.00633	CcSEcCtD
Halofantrine—Stomatitis—Etoposide—germ cell cancer	0.00122	0.00626	CcSEcCtD
Halofantrine—Discomfort—Bleomycin—germ cell cancer	0.00122	0.00626	CcSEcCtD
Halofantrine—Malaise—Dactinomycin—germ cell cancer	0.00122	0.00626	CcSEcCtD
Halofantrine—Decreased appetite—Vinblastine—germ cell cancer	0.00122	0.00625	CcSEcCtD
Halofantrine—Constipation—Vinblastine—germ cell cancer	0.0012	0.00615	CcSEcCtD
Halofantrine—Pulmonary oedema—Methotrexate—germ cell cancer	0.00119	0.00612	CcSEcCtD
Halofantrine—Confusional state—Bleomycin—germ cell cancer	0.00119	0.00612	CcSEcCtD
Halofantrine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00118	0.00607	CcSEcCtD
Halofantrine—Visual impairment—Cisplatin—germ cell cancer	0.00118	0.00607	CcSEcCtD
Halofantrine—Feeling abnormal—Vinblastine—germ cell cancer	0.00116	0.00592	CcSEcCtD
Halofantrine—Myalgia—Dactinomycin—germ cell cancer	0.00115	0.00591	CcSEcCtD
Halofantrine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00115	0.0059	CcSEcCtD
Halofantrine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00115	0.00588	CcSEcCtD
Halofantrine—Tinnitus—Cisplatin—germ cell cancer	0.00114	0.00587	CcSEcCtD
Halofantrine—Discomfort—Dactinomycin—germ cell cancer	0.00114	0.00584	CcSEcCtD
Halofantrine—Anorexia—Bleomycin—germ cell cancer	0.00113	0.00579	CcSEcCtD
Halofantrine—Malaise—Ifosfamide—germ cell cancer	0.00112	0.00573	CcSEcCtD
Halofantrine—Abdominal pain—Vinblastine—germ cell cancer	0.00111	0.00568	CcSEcCtD
Halofantrine—Arrhythmia—Cisplatin—germ cell cancer	0.0011	0.00562	CcSEcCtD
Halofantrine—Palpitations—Ifosfamide—germ cell cancer	0.0011	0.00562	CcSEcCtD
Halofantrine—Cough—Ifosfamide—germ cell cancer	0.00108	0.00555	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00108	0.00553	CcSEcCtD
Halofantrine—Convulsion—Ifosfamide—germ cell cancer	0.00107	0.00551	CcSEcCtD
Halofantrine—Paraesthesia—Bleomycin—germ cell cancer	0.00106	0.00545	CcSEcCtD
Halofantrine—Chest pain—Ifosfamide—germ cell cancer	0.00106	0.00541	CcSEcCtD
Halofantrine—Myalgia—Ifosfamide—germ cell cancer	0.00106	0.00541	CcSEcCtD
Halofantrine—Arthralgia—Ifosfamide—germ cell cancer	0.00106	0.00541	CcSEcCtD
Halofantrine—Anorexia—Dactinomycin—germ cell cancer	0.00105	0.0054	CcSEcCtD
Halofantrine—Discomfort—Ifosfamide—germ cell cancer	0.00104	0.00535	CcSEcCtD
Halofantrine—Decreased appetite—Bleomycin—germ cell cancer	0.00103	0.00528	CcSEcCtD
Halofantrine—Confusional state—Ifosfamide—germ cell cancer	0.00102	0.00523	CcSEcCtD
Halofantrine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00101	0.00519	CcSEcCtD
Halofantrine—Chills—Etoposide—germ cell cancer	0.00101	0.00518	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00101	0.00516	CcSEcCtD
Halofantrine—Asthenia—Vinblastine—germ cell cancer	0.00101	0.00516	CcSEcCtD
Halofantrine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000994	0.0051	CcSEcCtD
Halofantrine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000992	0.00509	CcSEcCtD
Halofantrine—Feeling abnormal—Bleomycin—germ cell cancer	0.000976	0.005	CcSEcCtD
Halofantrine—Anorexia—Ifosfamide—germ cell cancer	0.000964	0.00495	CcSEcCtD
Halofantrine—Malaise—Cisplatin—germ cell cancer	0.000964	0.00494	CcSEcCtD
Halofantrine—Decreased appetite—Dactinomycin—germ cell cancer	0.00096	0.00492	CcSEcCtD
Halofantrine—Diarrhoea—Vinblastine—germ cell cancer	0.000959	0.00492	CcSEcCtD
Halofantrine—Fatigue—Dactinomycin—germ cell cancer	0.000952	0.00488	CcSEcCtD
Halofantrine—Back pain—Etoposide—germ cell cancer	0.000947	0.00486	CcSEcCtD
Halofantrine—Urticaria—Bleomycin—germ cell cancer	0.00094	0.00482	CcSEcCtD
Halofantrine—Dizziness—Vinblastine—germ cell cancer	0.000927	0.00475	CcSEcCtD
Halofantrine—Convulsion—Cisplatin—germ cell cancer	0.000926	0.00475	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000922	0.00473	CcSEcCtD
Halofantrine—Myalgia—Cisplatin—germ cell cancer	0.00091	0.00467	CcSEcCtD
Halofantrine—Feeling abnormal—Dactinomycin—germ cell cancer	0.00091	0.00467	CcSEcCtD
Halofantrine—Paraesthesia—Ifosfamide—germ cell cancer	0.000908	0.00466	CcSEcCtD
Halofantrine—Ill-defined disorder—Etoposide—germ cell cancer	0.000908	0.00466	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000903	0.00463	CcSEcCtD
Halofantrine—Discomfort—Cisplatin—germ cell cancer	0.000899	0.00461	CcSEcCtD
Halofantrine—Vomiting—Vinblastine—germ cell cancer	0.000891	0.00457	CcSEcCtD
Halofantrine—Malaise—Etoposide—germ cell cancer	0.000883	0.00453	CcSEcCtD
Halofantrine—Decreased appetite—Ifosfamide—germ cell cancer	0.000879	0.00451	CcSEcCtD
Halofantrine—Headache—Vinblastine—germ cell cancer	0.000878	0.0045	CcSEcCtD
Halofantrine—Abdominal pain—Dactinomycin—germ cell cancer	0.000873	0.00448	CcSEcCtD
Halofantrine—Fatigue—Ifosfamide—germ cell cancer	0.000872	0.00447	CcSEcCtD
Halofantrine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000872	0.00447	CcSEcCtD
Halofantrine—Constipation—Ifosfamide—germ cell cancer	0.000865	0.00444	CcSEcCtD
Halofantrine—Cough—Etoposide—germ cell cancer	0.000854	0.00438	CcSEcCtD
Halofantrine—Asthenia—Bleomycin—germ cell cancer	0.000849	0.00436	CcSEcCtD
Halofantrine—Convulsion—Etoposide—germ cell cancer	0.000848	0.00435	CcSEcCtD
Halofantrine—Pruritus—Bleomycin—germ cell cancer	0.000838	0.0043	CcSEcCtD
Halofantrine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000834	0.00428	CcSEcCtD
Halofantrine—Chest pain—Etoposide—germ cell cancer	0.000834	0.00427	CcSEcCtD
Halofantrine—Nausea—Vinblastine—germ cell cancer	0.000833	0.00427	CcSEcCtD
Halofantrine—Anorexia—Cisplatin—germ cell cancer	0.000831	0.00426	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000827	0.00424	CcSEcCtD
Halofantrine—Discomfort—Etoposide—germ cell cancer	0.000824	0.00422	CcSEcCtD
Halofantrine—Confusional state—Etoposide—germ cell cancer	0.000806	0.00413	CcSEcCtD
Halofantrine—Urticaria—Ifosfamide—germ cell cancer	0.000804	0.00412	CcSEcCtD
Halofantrine—Abdominal pain—Ifosfamide—germ cell cancer	0.0008	0.0041	CcSEcCtD
Halofantrine—Anaphylactic shock—Etoposide—germ cell cancer	0.000799	0.0041	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000795	0.00408	CcSEcCtD
Halofantrine—Asthenia—Dactinomycin—germ cell cancer	0.000792	0.00406	CcSEcCtD
Halofantrine—Paraesthesia—Cisplatin—germ cell cancer	0.000783	0.00402	CcSEcCtD
Halofantrine—Anorexia—Etoposide—germ cell cancer	0.000762	0.00391	CcSEcCtD
Halofantrine—Decreased appetite—Cisplatin—germ cell cancer	0.000758	0.00389	CcSEcCtD
Halofantrine—Diarrhoea—Dactinomycin—germ cell cancer	0.000755	0.00387	CcSEcCtD
Halofantrine—Vomiting—Bleomycin—germ cell cancer	0.000753	0.00386	CcSEcCtD
Halofantrine—Rash—Bleomycin—germ cell cancer	0.000746	0.00383	CcSEcCtD
Halofantrine—Dermatitis—Bleomycin—germ cell cancer	0.000746	0.00382	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—germ cell cancer	0.000731	0.00375	CcSEcCtD
Halofantrine—Asthenia—Ifosfamide—germ cell cancer	0.000726	0.00372	CcSEcCtD
Halofantrine—Feeling abnormal—Cisplatin—germ cell cancer	0.000719	0.00369	CcSEcCtD
Halofantrine—Paraesthesia—Etoposide—germ cell cancer	0.000718	0.00368	CcSEcCtD
Halofantrine—Pruritus—Ifosfamide—germ cell cancer	0.000716	0.00367	CcSEcCtD
Halofantrine—Nausea—Bleomycin—germ cell cancer	0.000703	0.00361	CcSEcCtD
Halofantrine—Vomiting—Dactinomycin—germ cell cancer	0.000702	0.0036	CcSEcCtD
Halofantrine—Rash—Dactinomycin—germ cell cancer	0.000696	0.00357	CcSEcCtD
Halofantrine—Decreased appetite—Etoposide—germ cell cancer	0.000695	0.00356	CcSEcCtD
Halofantrine—Diarrhoea—Ifosfamide—germ cell cancer	0.000692	0.00355	CcSEcCtD
Halofantrine—Fatigue—Etoposide—germ cell cancer	0.000689	0.00353	CcSEcCtD
Halofantrine—Constipation—Etoposide—germ cell cancer	0.000683	0.0035	CcSEcCtD
Halofantrine—Dizziness—Ifosfamide—germ cell cancer	0.000669	0.00343	CcSEcCtD
Halofantrine—Feeling abnormal—Etoposide—germ cell cancer	0.000658	0.00338	CcSEcCtD
Halofantrine—Nausea—Dactinomycin—germ cell cancer	0.000656	0.00336	CcSEcCtD
Halofantrine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000653	0.00335	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—germ cell cancer	0.000649	0.00333	CcSEcCtD
Halofantrine—Vomiting—Ifosfamide—germ cell cancer	0.000643	0.0033	CcSEcCtD
Halofantrine—Rash—Ifosfamide—germ cell cancer	0.000638	0.00327	CcSEcCtD
Halofantrine—Dermatitis—Ifosfamide—germ cell cancer	0.000637	0.00327	CcSEcCtD
Halofantrine—Urticaria—Etoposide—germ cell cancer	0.000635	0.00326	CcSEcCtD
Halofantrine—Abdominal pain—Etoposide—germ cell cancer	0.000632	0.00324	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—germ cell cancer	0.000628	0.00322	CcSEcCtD
Halofantrine—Asthenia—Cisplatin—germ cell cancer	0.000626	0.00321	CcSEcCtD
Halofantrine—Chills—Methotrexate—germ cell cancer	0.000604	0.0031	CcSEcCtD
Halofantrine—Nausea—Ifosfamide—germ cell cancer	0.000601	0.00308	CcSEcCtD
Halofantrine—Diarrhoea—Cisplatin—germ cell cancer	0.000597	0.00306	CcSEcCtD
Halofantrine—Asthenia—Etoposide—germ cell cancer	0.000573	0.00294	CcSEcCtD
Halofantrine—Back pain—Methotrexate—germ cell cancer	0.000567	0.00291	CcSEcCtD
Halofantrine—Pruritus—Etoposide—germ cell cancer	0.000565	0.0029	CcSEcCtD
Halofantrine—Vomiting—Cisplatin—germ cell cancer	0.000555	0.00284	CcSEcCtD
Halofantrine—Rash—Cisplatin—germ cell cancer	0.00055	0.00282	CcSEcCtD
Halofantrine—Dermatitis—Cisplatin—germ cell cancer	0.000549	0.00282	CcSEcCtD
Halofantrine—Diarrhoea—Etoposide—germ cell cancer	0.000547	0.0028	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000544	0.00279	CcSEcCtD
Halofantrine—Malaise—Methotrexate—germ cell cancer	0.000529	0.00271	CcSEcCtD
Halofantrine—Dizziness—Etoposide—germ cell cancer	0.000528	0.00271	CcSEcCtD
Halofantrine—Nausea—Cisplatin—germ cell cancer	0.000518	0.00266	CcSEcCtD
Halofantrine—Cough—Methotrexate—germ cell cancer	0.000512	0.00262	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—germ cell cancer	0.000508	0.00261	CcSEcCtD
Halofantrine—Vomiting—Etoposide—germ cell cancer	0.000508	0.00261	CcSEcCtD
Halofantrine—Rash—Etoposide—germ cell cancer	0.000504	0.00258	CcSEcCtD
Halofantrine—Dermatitis—Etoposide—germ cell cancer	0.000503	0.00258	CcSEcCtD
Halofantrine—Headache—Etoposide—germ cell cancer	0.000501	0.00257	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—germ cell cancer	0.000499	0.00256	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—germ cell cancer	0.000499	0.00256	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—germ cell cancer	0.000499	0.00256	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—germ cell cancer	0.000493	0.00253	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—germ cell cancer	0.000483	0.00247	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000479	0.00245	CcSEcCtD
Halofantrine—Nausea—Etoposide—germ cell cancer	0.000475	0.00243	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—germ cell cancer	0.000456	0.00234	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000436	0.00224	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—germ cell cancer	0.00043	0.0022	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—germ cell cancer	0.000421	0.00216	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—germ cell cancer	0.000416	0.00213	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—germ cell cancer	0.000413	0.00212	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—germ cell cancer	0.000394	0.00202	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000391	0.00201	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—germ cell cancer	0.00038	0.00195	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—germ cell cancer	0.000378	0.00194	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—germ cell cancer	0.000343	0.00176	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—germ cell cancer	0.000339	0.00174	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—germ cell cancer	0.000327	0.00168	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—germ cell cancer	0.000316	0.00162	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—germ cell cancer	0.000304	0.00156	CcSEcCtD
Halofantrine—Rash—Methotrexate—germ cell cancer	0.000302	0.00155	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—germ cell cancer	0.000301	0.00155	CcSEcCtD
Halofantrine—Headache—Methotrexate—germ cell cancer	0.0003	0.00154	CcSEcCtD
Halofantrine—Nausea—Methotrexate—germ cell cancer	0.000284	0.00146	CcSEcCtD
